Table 1

Demographic and clinical data

Median IQR Min Max
Vancomycin continuous (n=56)
 Age (years)6961–741892
 Body weight (kg)8066–9650150
 Height (cm)175170–179150198
 BMI (kg/m2)26.222.9–31.216.550.8
 BSA (m2)1.931.82–2.141.482.56
 Serum creatinine (μmol/L)12288–19433332
 CKD-EPI creatinine clearance (mL/s)0.900.50–1.290.263.36
Vancomycin intermittent (n=45)
 Age (years)6860–742486
 Body weight (kg)8071–10055255
 Height (cm)175168–175155207
 BMI (kg/m2)26.124.1–32.720.465.3
 BSA (m2)1.961.81–2.151.592.89
 Serum creatinine (μmol/L)10973–20038424
 CKD-EPI creatinine clearance (mL/s)1.100.52–1.650.162.50
Amikacin (n=37)
 Age (years)6660–763692
 Body weight (kg)8068–8933134
 Height (cm)175170–180150190
 BMI (kg/m2)25.022.5–29.113.441.4
 BSA (m2)1.921.80–2.101.232.49
 Serum creatinine (μmol/L)165109–18028457
 CKD-EPI creatinine clearance (mL/s)0.680.53–1.090.152.11
Gentamicin (n=14)
 Age (years)6961–733690
 Body weight (kg)8259–10148255
 Height (cm)170161–175153190
 BMI (kg/m2)24.523.0–35.618.365.3
 BSA (m2)1.981.60–2.151.472.89
 Serum creatinine (μmol/L)133102–20135475
 CKD-EPI creatinine clearance (mL/s)0.910.52–1.110.131.56
  • BMI, body mass index; BSA, body surface area; CKD-EPI, Chronic Kidney Disease Epidemiology Collaboration.